{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:35:37Z","timestamp":1771259737801,"version":"3.50.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is a disorder characterized by motor symptoms, such as rigidity, akinesia, and resting tremor, as well as non-motor symptoms, including psychiatric manifestations and autonomic failure. The prevalence of PD increases with age, and the condition is more common in men than in women. Conversely, polypharmacy has emerged as a paramount medical concern, especially among older patients, correlating with medicines\u2019 adverse effects, interactions between medicines, frequent admissions to the hospital, and a high risk of morbidity and mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case description<\/jats:title><jats:p>We encountered an older male patient with idiopathic PD and mild renal dysfunction. Originally prescribed 14 types of medicines, including anti-PD drugs, the patient developed delirium and epileptic seizures during hospitalization. After reducing the number of medications, including amantadine, the symptoms significantly improved. This clinical course suggests that polypharmacy, in addition to PD itself, poses a significant risk of delirium and epileptic seizures, even in patients with mild renal dysfunction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This report is indicative of the risk of polypharmacy and highlights the importance of citing drug interactions for a correct diagnosis in patients presenting with complex symptoms.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1415988","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T05:10:39Z","timestamp":1721279439000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Exacerbation of delirium and epileptic seizures in an older man with idiopathic Parkinson\u2019s disease due to multiple prescriptions: a case report"],"prefix":"10.3389","volume":"11","author":[{"given":"Takuya","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Mashiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Oizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Ishiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juri","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiro","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Sumitomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3233\/JPD-230250","article-title":"The etiology of Parkinson\u2019s disease: new perspectives from gene-environment interactions","volume":"13","author":"Bogers","year":"2023","journal-title":"J Parkinsons Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/13543776.2019.1567712","article-title":"Research and development of anti-Parkinson's drugs: an analysis from the perspective of technology flows measured by patent citations","volume":"29","author":"Qu","year":"2019","journal-title":"Expert Opin Ther Pat"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"112317","DOI":"10.1016\/j.exger.2023.112317","article-title":"Polypharmacy, physical activity, and sedentary time in older adults: a scoping review","volume":"183","author":"de Souza","year":"2023","journal-title":"Exp Gerontol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2165\/00002018-200326090-00004","article-title":"Treatment of psychosis in Parkinson\u2019s disease: safety considerations","volume":"26","author":"Fernandez","year":"2003","journal-title":"Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.2174\/1381612828666220428102802","article-title":"Psychosis in Parkinson\u2019s disease: looking beyond dopaminergic treatments","volume":"28","author":"Rojas","year":"2022","journal-title":"Curr Pharm Des"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1034\/j.1601-5215.2002.140507.x","article-title":"Psychiatric symptoms typical of patients with dementia with Lewy bodies\u2014similarity to those of levodopa-induced psychosis","volume":"14","author":"Iseki","year":"2002","journal-title":"Acta Neuropsychiatr"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C","article-title":"The role of dopamine in epilepsy","volume":"22","author":"Starr","year":"1996","journal-title":"Synapse"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2020.0603","article-title":"What you need to know about: delirium in older adults in hospital","volume":"82","author":"Jones","year":"2021","journal-title":"Br J Hosp Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2217\/nmt-2017-0028","article-title":"Parkinson\u2019s disease psychosis: presentation, diagnosis and management","volume":"7","author":"Schneider","year":"2017","journal-title":"Neurodegener Dis Manag"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/mds.26170","article-title":"Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease","volume":"30","author":"Weintraub","year":"2015","journal-title":"Mov Disord"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1212\/WNL.0000000000000801","article-title":"Course of psychiatric symptoms and global cognition in early Parkinson disease","volume":"83","author":"de la Riva","year":"2014","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s40265-016-0600-5","article-title":"Psychosis in Parkinson\u2019s disease: epidemiology, pathophysiology, and management","volume":"76","author":"Chang","year":"2016","journal-title":"Drugs"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/mds.25003","article-title":"Psychosis in Parkinson\u2019s disease without dementia: common and comorbid with other non-motor symptoms","volume":"27","author":"Lee","year":"2012","journal-title":"Mov Disord"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1002\/mds.23806","article-title":"Payami H disease-related and genetic correlates of psychotic symptoms in Parkinson's disease","volume":"26","author":"Factor","year":"2011","journal-title":"Mov Disord"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF02252620","article-title":"Seizure promotion by D1 agonists dose not correlate with other dopaminergic properties","volume":"6","author":"Starr","year":"1993","journal-title":"J Neural Transm"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e19415","DOI":"10.1371\/journal.pone.0019415","article-title":"Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif268 and arc\/Arg3.1 expression in mouse dentate gyrus","volume":"6","author":"Gangarossa","year":"2011","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.nbd.2011.09.006","article-title":"Borsodi a dopamine abnormalities in the neocortex of patients with temporal lobe epilepsy","volume":"45","author":"Rocha","year":"2012","journal-title":"Neurobiol Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.yebeh.2018.09.001","article-title":"Kanemoto K pharmacotherapy in patients with epilepsy and psychosis","volume":"88","author":"de Toffol","year":"2018","journal-title":"Epilepsy Behav"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1124\/pharmrev.122.000618","article-title":"Gaskill PJ dopamine, immunity, and disease","volume":"75","author":"Channer","year":"2023","journal-title":"Pharmacol Rev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ana.25157","article-title":"Parkinson disease and the risk of epileptic seizures","volume":"83","author":"Gruntz","year":"2018","journal-title":"Ann Neurol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"ref23","first-page":"32","article-title":"Polypharmacy: evaluating risks and deprescribing","volume":"1","author":"Halli-Tierney","year":"2019","journal-title":"Am Fam Physician"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.2215\/CJN.03940321","article-title":"Association of Polypharmacy with kidney disease progression in adults with CKD","volume":"16","author":"Kimura","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12875-023-02005-9","article-title":"The association between renal impairment and polypharmacy among older Palestinian patients: a multi-center cross-sectional study","volume":"24","author":"Naghnaghia","year":"2023","journal-title":"BMC. Prim Care"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1001\/jama.208.7.1168","article-title":"Amantadine in the treatment of Parkinson\u2019s disease","volume":"208","author":"Schwab","year":"1969","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/ccr3.2803","article-title":"Amantadine intoxication despite moderate renal dysfunction: a case of combined use with donepezil","volume":"8","author":"Okada","year":"2020","journal-title":"Clin Case Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/0003-9993(93)90072-I","article-title":"Amantadine-induced coma","volume":"74","author":"Macchio","year":"1993","journal-title":"Arch Phys Med Rehabil"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000095147","article-title":"Severe reversible neurological complications following amantadine treatment in three elderly patients with renal insufficiency","volume":"56","author":"Nakata","year":"2006","journal-title":"Eur Neurol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1415988\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T05:10:41Z","timestamp":1721279441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1415988\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":29,"alternative-id":["10.3389\/fmed.2024.1415988"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1415988","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"article-number":"1415988"}}